Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, March 3, 2021
[ Wed, Mar 03rd 2021
] - WOPRAI
[ Wed, Mar 03rd 2021
] - WOPRAI
[ Wed, Mar 03rd 2021
] - WOPRAI
[ Wed, Mar 03rd 2021
] - WOPRAI
[ Wed, Mar 03rd 2021
] - WOPRAI
[ Wed, Mar 03rd 2021
] - WOPRAI
[ Wed, Mar 03rd 2021
] - WOPRAI
[ Wed, Mar 03rd 2021
] - WOPRAI
[ Wed, Mar 03rd 2021
] - WOPRAI
[ Wed, Mar 03rd 2021
] - WOPRAI
[ Wed, Mar 03rd 2021
] - WOPRAI
[ Wed, Mar 03rd 2021
] - WOPRAI
[ Wed, Mar 03rd 2021
] - WOPRAI
[ Wed, Mar 03rd 2021
] - WOPRAI
[ Wed, Mar 03rd 2021
] - WOPRAI
[ Wed, Mar 03rd 2021
] - WOPRAI
[ Wed, Mar 03rd 2021
] - WOPRAI
[ Wed, Mar 03rd 2021
] - WOPRAI
[ Wed, Mar 03rd 2021
] - WOPRAI
[ Wed, Mar 03rd 2021
] - WOPRAI
[ Wed, Mar 03rd 2021
] - WOPRAI
[ Wed, Mar 03rd 2021
] - WOPRAI
Tue, March 2, 2021
[ Tue, Mar 02nd 2021
] - WOPRAI
[ Tue, Mar 02nd 2021
] - WOPRAI
[ Tue, Mar 02nd 2021
] - WOPRAI
[ Tue, Mar 02nd 2021
] - WOPRAI
[ Tue, Mar 02nd 2021
] - WOPRAI
[ Tue, Mar 02nd 2021
] - WOPRAI
[ Tue, Mar 02nd 2021
] - WOPRAI
Joseph Stringer Maintained (VIR) at Strong Buy with Increased Target to $75 on, Mar 2nd, 2021
Joseph Stringer of Needham, Maintained "Vir Biotechnology, Inc." (VIR) at Strong Buy with Increased Target from $62 to $75 on, Mar 2nd, 2021.
Joseph has made no other calls on VIR in the last 4 months.
There are 2 other peers that have a rating on VIR. Out of the 2 peers that are also analyzing VIR, 0 agree with Joseph's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Joseph
- Anupam Rama of "JP Morgan" Downgraded from Hold to Sell and Held Target at $30 on, Wednesday, January 27th, 2021
- Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $125 on, Wednesday, January 20th, 2021
